ENDO INTERNATIONAL for ENDO INTERNATIONAL
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Government Issues GOV
H.R. 3010, Regulatory Accountability Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Taxation/Internal Revenue Code TAX
H.R. 2632, Life Sciences Jobs and Investment Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Copyright/Patent/Trademark CPT
Oversight of implementation of the America Invents Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Health Issues HCR
S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 3988, Generic Drug and Biosimilar User Fee Act of 2012 S. 3187, FDA Safety and Innovation Act H.R. 5998, USPSTF Transparency and Accountability Act H.R. 6544, Manufacturing Innovation in America Act H.R. 6160, Stop Tampering of Prescription Pills Act H.R. 436, Health Care Cost Reduction Act regarding medical device excise tax repeal Issues relating to bioequivalence and related administrative procedures Issues relating to DEA quotas for controlled substances Oversight of DEA Issues relating to prescription drug abuse Issues relating to incentives for tamper-resistant formulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.